![NovoCure Limited logo](/logos/NVCR.webp)
NovoCure Limited
NASDAQ:NVCR
Overview | Financials
Company Name | NovoCure Limited |
Symbol | NVCR |
Currency | USD |
Price | 16.88 |
Market Cap | 1,826,702,960 |
Dividend Yield | 0% |
52-week-range | 10.87 - 24.735 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Asaf Danziger |
Website | https://www.novocure.com |
An error occurred while fetching data.
About NovoCure Limited
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD